(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Best Internet based Course for Learning Another Dialect: Which Stage Do You Like? - 2The most effective method to Help a Friend or family member Determined to have Cellular breakdown in the lungs
- 3Sustaining Public activity and Connections: Key Methodologies
- 4Court clears Beersheba assault suspect of link to Haymanut Kasau disappearance, extends detention
- 5Munich Security Conference chief defends inviting AfD lawmakers
- Select Your Cherished Fish
- James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster
- First Greenland, now Iceland? Annexation joke by Trump ally gets frosty response in the Arctic nation.
- 6 Arranging Administrations to Change Your Open air Space
- Where America’s CO2 emissions come from – what you need to know, in charts
- AI is making spacecraft propulsion more efficient – and could even lead to nuclear-powered rockets
- Make your choice for the music application with the most amicable connection point!
- As world leaders enter climate talks, people in poverty have the most at stake
- Astronauts beam home Christmas wishes from International Space Station: 'I think we may be orbiting a little higher than Santa' (video)
